Hypothetical cytomegalovirus intervention

1. Hypothetical cytomegalovirus intervention lowers the risk of heart disease in humans (-2.89 percentage points (95% CI: 0.93, 4.86)).

   “a 2·89 (95% CI: 0·93, 4·86) percentage points reduction of heart diseases”

   Humanshypothetical intervention decreasing CMV IgG below highest quartilemales

   Health impact of a hypothetical intervention on immune burden of cytomegalovirus (CMV) among older adults in the US: a prospective analysis of the Health and Retirement Study Cohort

   Lancet regional health. Americas·May 12, 2025

More on Heart disease

1. Hypothetical cytomegalovirus intervention lowers the risk of hypertension in humans (-1.81 percentage points (95% CI: 0.75, 2.86)).

   “a 1·81 (95% CI: 0·75, 2·86) percentage points reduction of high blood pressure cases among Non-Hispanic White (NHW) women”

   Humanshypothetical intervention decreasing CMV IgG below highest quartilefemales

   Health impact of a hypothetical intervention on immune burden of cytomegalovirus (CMV) among older adults in the US: a prospective analysis of the Health and Retirement Study Cohort

   Lancet regional health. Americas·May 12, 2025

More on Hypertension

1. Hypothetical cytomegalovirus intervention lowers the risk of diabetes in humans (-3.57 percentage points (95% CI: 1.54, 5.60)).

   “a hypothetical intervention that decreased CMV IgG below the highest quartile level in 2016 would result in a 3·57 (95% Confidence Interval: 1·54, 5·60) percentage points reduction of diabetes cases”

   Humanshypothetical intervention decreasing CMV IgG below highest quartilefemales

   Health impact of a hypothetical intervention on immune burden of cytomegalovirus (CMV) among older adults in the US: a prospective analysis of the Health and Retirement Study Cohort

   Lancet regional health. Americas·May 12, 2025

More on Diabetes